Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

143 results about "Time resolved fluorescence immunoassay" patented technology

Photon counting multi-channel time-resolved fluorescence immunoassay system and counting method

The invention belongs to the technical field of fluorescence immunoassay and relates to a photon counting multi-channel time-resolved fluorescence immunoassay system which comprises a light source module, a detection module and a time marked photon counting analysis/control module. At the same time, the invention relates to a counting method adopted by the system. The counting method of exciting a sample to be detected with pulse light, sending a fluorescence signal generated by the sample after excitation into a PMT (Photo Multiplier Tube) photon counting head and outputting a pulse signal comprises the following steps of taking cycles of the excitation pulse light as counting cycles, dividing each counting cycle into a plurality of time intervals with the same width, accumulating photons detected after sending excitation light pulses of each counting cycle into a memory corresponding to a corresponding time window, that is marking the positions of the photons in the pulse cycles with the intervals where the time windows are located, and uploading data in the memory into an upper computer after counting for the cycles. The multi-channel time-resolved fluorescence immunoassay system is low in cost and has very high sensitivity.
Owner:TIANJIN UNIV

Protein chip reagent kit and method for comprehensively detecting lung cancer marker

The invention belongs to the technical field of biology and relates to a protein chip reagent kit and a method for comprehensively detecting a lung cancer marker. The protein chip reagent kit for comprehensively detecting the lung cancer marker comprises: (1) a chip (1) and (2) a reaction agent and a detection agent, wherein a plurality of specific antibodies are simultaneously fixed on the chip, can generate antibody-antigen reaction with the lung cancer marker and are fixed on a bottom film of the chip to form a plurality of independent recognition sites; and the reaction agent and the detection agent are used for detecting whether a matter capable of generating antibody-antigen reaction with the specific antibodies exists in a sample to be detected or not through a TRFIA (Time Resolved Fluorescence Immunoassay) method. The reagent kit and the method have the beneficial effects that the six indexes of NSE (Neuron Specific Enolase), SCC (Squamous Cell Carcinoma), CEA (Carcino Embryonie Antigen), CA (Carbonic Anhydrase) 19-9, CYFR (Cytokeratin Fragment) A21-1 and pro-GRP (Glass Reinforced Plastic) can be simultaneously detected, the detection accuracy is improved, the repetitive experimental steps are reduced, and the time and the cost are saved.
Owner:河南生生医疗器械有限公司

Double-labeling time-resolved fluorescence immunoassay method and kit for HIV (human immunodeficiency virus) antibody and HIV-1p24 antigen

The invention discloses a double-labeling time-resolved fluorescence immunoassay method and kit for HIV (human immunodeficiency virus) antibody-HIV-1p24 antigen. The analytical method mainly comprises the steps of preparing a solid phase carrier coated with an HIV recombinant antigen and an HIV-1p24 monoclonal antibody simultaneously; preparing biotin-labeled HIV-1p24 monoclonal antibody; preparing lanthanide 1-labeled HIV recombinant antigen; preparing lanthanide 2-labeled streptavidin; adding a calibrator containing HIV standard antibody and HIV-1p24 standard antigen or a sample to be tested into the solid phase carrier coated with the antigen and the antibody, adding the biotin-labeled HIV-1p24 antibody, incubating, washing, then adding the lanthanide 1-labeled HIV antigen and the lanthanide 2-labeled streptavidin, incubating again, washing, and adding enhancement solution for fluorescence detection. The analytical method overcomes the difficulty that the antigen and the antibody cannot be distinguished in the existing joint detection for HIV antigen and antibody, realizes simultaneous and quantitative detection of the HIV antibody and the HIV-1p24 antigen and therefore shortens the window phase of HIV detection.
Owner:GUANGZHOU FENGHUA BIOENG

Method for screening single chain antibodies of Microcystin-LR and verification thereof

The invention relates to a method for screening single chain antibodies of Microcystin-LR and verification thereof. The method comprises the following steps: carrying out two rounds of affinity screening on the biotinylated Microcystin-LR in a human source synthetic antibody library by using an avidin labeled magnetic bead and a negative screening method; extracting total plasmid DNA from phage colonies produced in the second round, carrying out enzyme digestion with enzyme Sfi I, recycling gel to obtain single chain antibody genes, connecting the single chain antibody genes with soluble expression carrier pAK100CL which is processed by enzyme digestion in the same way, and electrically transforming the connected carrier into colibacillus XL1-Blue to obtain soluble expression single chain antibodies; and verifying the soluble expression single chain antibodies by using a competitive time-resolved fluorescence immune analytical method. The invention has the advantage of quick, simple and convenient screening, and can well expose the Microcystin-LR three-dimensional structure into the incubation system. The verification on the screening result has the advantages of high detection signal and strong anti-interference capacity against stroma.
Owner:JIANGSU ACADEMY OF AGRICULTURAL SCIENCES

Novel detection method and kit for synchronously detecting concentration of free kappa light chain and free lambda light chain

The invention discloses a time-resolved fluoroimmunoassay (TRFIA) kit and a detection method thereof for synchronously detecting the concentration of a free kappa light chain and a free lambda light chain. The kit comprises: 1) an antibody synchronously aiming at a heavy chain and a light chain of a human antibody, 2) an anti-free kappa light chain antibody labelled by lanthanide, 3) an anti-free lambda light chain antibody labelled by another lanthanide, 4) a standard substance of the free kappa light chain and a standard substance of the free lambda light chain, 5) a buffer, 6) a washing liquid, and 7) an enhancement solution. According to the invention, the antibody synchronously aiming at the heavy chain and the light chain of the human antibody is used as a capture antibody, other two antibodies respectively aiming at the free kappa light chain and the free lambda light chain are used as the labelled antibodies, double labeling TRFIA detection principles are used, thus the novel detection method for synchronously detecting the concentration of the free kappa light chain and the free lambda light chain is established. The method provided by the invention has the advantages of high sensitivity, strong specificity and good stability, and can realize high degrees of automation.
Owner:SHANGHAI HUJING BIO TECH CO LTD +1

Double rare earth coordination compound, Ag at SiO2 fluorescent nano particle doped with the same and preparation method thereof

The invention relates to a double rare earth coordination compound, an Ag at SiO2 fluorescent nano particle doped with the same and a preparation method thereof. The fluorescent nano particle takes Ag doped with the double rare earth coordination compound Eu3<+> / Tb3<+>-PABA-DTPA-APTMS as an inner core; silicon dioxide with a mesh structure is covered on the surface of the inner core; an active amino group is arranged on the surface of the silicon dioxide, wherein the ratio of the double rare earth coordination Eu3<+> / Tb3<+>-PABA-DTPA-APTMS to the Ag is 1:0.176-0.2; and the mass ratio of the inner core to the silicon dioxide is 1:5-12 and each milligram of nano particle contains 595-630nmol of amino groups. The fluorescence intensity of Eu3<+> and Tb3<+> in the nano particle at the maximum transmitting peak is improved by 3.0 and 3.4 times compared with the fluorescence intensity of a SiO2 fluorescent nano particle doped with the Eu3<+> / Tb3<+>-PABA-DTPA-APTMS without an Ag core; the prepared nano particle is regularly spherical, is uniform in size with the particle size of 120+ / -5nm and has favorable monodispersity and light stability; and an amino group is arranged on the surface of the nano particle and directly reacts with a biomolecule without surface modification. The nano particle is expected to be used as a novel rare earth fluorescent probe which is applied to the time distinguishing fluorescent immunoassay for high-sensitivity detection, a biosensor, a biological chip and the like.
Owner:SHANGHAI UNIV

Homogeneous phase time discrimination fluorescence immunity analysis chelating agent and its preparing method

InactiveCN101221169AAdvantage designAdvantage structureBiological testingLuminescent compositionsSolubilityTriplet state
The invention relates to a homogeneous time resolved fluorescence immunoassay chelating agent and the preparation method thereof. The chelating agent is N, N, N', N'-((2, 6-di(3'-aminomethyl)-1-pyrazole)-4-(4-isothiocyanate(phenylacetylene)-pyridine))-tetraacetic acid. A luminous group is 2, 6-di(pyrazole) pyridine; the invention has high triplet-state energy level, the excitation wavelength after the combination with rare earth ions is 320nm, the emission wavelength is 520 to 620nm, the luminous service life is 2.99ms, the quantum yield is 0.58, the invention is in line with the requirements of homogeneous TRFIA to be combined with phenylacetylene at the pyridine 4-position, and the acetylene bond can block protein macromolecules from consuming luminous energy. The phenyl 4-linking isothiocyanate at the pyridine 4-position can be coupled with protein without injury, so as to be conductive to the high-efficient measurement of the luminescence of the chelating agent. The polyammonia polycarboxyl structure of 11 coordination site can exclude the quenching function of water molecules on rare earth luminescence and improve the solubility of the chelating agent in water and the dynamic stability of the chelating agent in the water r solution.
Owner:CHANGCHUN INST OF APPLIED CHEMISTRY - CHINESE ACAD OF SCI

Method for detecting olaquindox by directly-competing TRFIA (Time Resolved Fluorescence Immunoassay)

The invention discloses a method for detecting olaquindox by a directly-competing TRFIA (Time Resolved Fluorescence Immunoassay). The method comprises the following steps of: respectively adding standard olaquindox solution or treated sample solution and europium-labeled monoclonal antibodies into each micropore of an antigen precoating strip, mixing to be uniform, incubating for 1 hour at the temperature of 37 DEG C, and washing the micropores for 3-5 times by using washing liquid; adding 200muL of enhancement solution into each micropore, and carrying out light-proof oscillating incubation for 10 minutes at the temperature of 37 DEG C; determining the fluorescence intensity value cps by using a time resolution meter; drawing a standard curve; calculating out the corresponding concentration of the olaquindox from the standard curve according to the cpsx/cps0 value of each sample, multiplying by the corresponding dilution ratio and calculating out the actual concentration of the olaquindox in the sample. The method disclosed by the invention has the advantages that the operation is simple and convenient, the sensitivity is high, the stability is good and the lowest detection limit can reach 0.83ng.mL<-1>.
Owner:ZHEJIANG GONGSHANG UNIVERSITY

Full-automatic magnetic-bead time resolution fluorescence immunoassay analyzer

The invention discloses a full-automatic magnetic-bead time resolution fluorescence immunoassay analyzer. The analyzer is divided into an inner chamber and an outer chamber by a rack; an electronic element box is fixed on the upper layer of the inner chamber, a dark chamber shell is positioned on the lower layer of the inner chamber, a dark chamber door device is arranged on the rack, and a dark chamber space of which one side is openable is formed by the dark chamber door device and the dark chamber shell; a tray module is positioned on the lower layer of the outer chamber, and a plurality ofreagent strips can be placed on the tray module, and are conveyed to the lower layer of the inner chamber or are withdrawn to the lower layer of the outer chamber; a puncturing liquid relief module is positioned on the upper layer of the outer chamber, can automatically pierce the film of the top surface of each reagent strip, and automatically suck or discharge liquid in the reagent; a scanningand value reading module is positioned on the lower layer of the inner chamber, is positioned in the dark chamber shell, and is used for triggering and reading fluorescence information of the reagentstrips after incubation; and by reasonable arrangement of the inner chamber and the outer chamber and in combination with compact and scientific design of the related functional module, the structureis simple and compact, the cost is low, furthermore, the degree of automation of the integral instrument is increased, and thus, the full-automatic magnetic-bead time resolution fluorescence immunoassay analyzer is quite suitable for being used and popularized in China medical units.
Owner:GUANGZHOU BIOKEY HEALTH TECH CO LTD

Time resolved fluoroimmunoassay kit for detecting chlorpromazine and detecting method thereof

The invention provides a kit for detecting chlorpromazine (CPZ) and a detecting method thereof, belonging to the technical field of time resolved fluoroimmunoassay (TRFIA) and used for detecting the content of CPZ in meat, fish and other animal derived foods. The kit prepared by the method is used for detecting CPZ by using TRFIA, and the detection is based on a labeled immunoreaction. A microporous plate is coated with CPZ-OVA (ovalbumin), a CPZ standard or sample is added, and a CPZ antibody is added; free CPZ competes for the CPZ antibody with the CPZ-OVA on the microporous plate, the CPZ antibody which is not connected is washed off and removed, Eu3+- antiMIgG is added, and the Eu3+- antiMIgG which is not connected is washed off and removed after the labeled immunoreaction; after an enhancing solution is added, the fluorescence intensity cps of the enhancing solution is detected by using a time-resolved fluorescence spectrofluorometer, the fluorescence intensity is in inverse proportion to the concentration of CPZ in the sample; and the content of CPZ in the detected sample can be determined in comparison with a standard curve. The kit for detecting CPZ provided by the invention has the advantages of simple structure, convenience in use, low cost and high sensitivity.
Owner:FOOD INSPECTION CENT OF CIQ SHENZHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products